Real-world use of elbasvir-grazoprevir in patients with chronic hepatitis C: retrospective analyses from the TRIO network.

S L FlammB BaconMichael P CurryS MilliganC U NwankwoN TsaiZobair M YounossiN Afdhal

Published in: Alimentary pharmacology & therapeutics (2018)

Elbasvir-grazoprevir is highly effective, and in this 2016 cohort, its use was predominantly in patients with HCV genotype 1 and as a 12-week therapy without ribavirin.

Keyphrases

hepatitis c virus
human immunodeficiency virus
liver fibrosis
clinical trial
stem cells
african american
cell therapy
mesenchymal stem cells
hiv infected
replacement therapy
chemotherapy induced